Tumor-infiltrating lymphocytes (TILs), especially the cytotoxic CD8 +T cells used for adoptive immunotherapy1–4 are excellent for the identification of tumor-targeting T cell receptors (TCRs). The gene discussed is CD8A; the disease is neoplasm.